MARKET

WVE

WVE

Wave Life Scienc
NASDAQ
3.460
-0.080
-2.26%
Opening 15:23 10/08 EDT
OPEN
3.480
PREV CLOSE
3.540
HIGH
3.505
LOW
3.365
VOLUME
1.88M
TURNOVER
--
52 WEEK HIGH
21.73
52 WEEK LOW
3.365
MARKET CAP
681.79M
P/E (TTM)
-3.1851
1D
5D
1M
3M
1Y
5Y
1D
Wave Life Sciences: FDA-Aligned AATD Registrational Path, Obesity Combination Study, and GSK Milestones Underscore Buy Rating and $42 Price Target
TipRanks · 1d ago
Weekly Report: what happened at WVE last week (0928-1002)?
Weekly Report · 3d ago
Weekly Buzz: EW, ABBV, MIRM Score FDA Wins, AZN, NVO Strike Deals; LLY, KOD Report Data
NASDAQ · 6d ago
Analysts Offer Insights on Healthcare Companies: Cigna (CI), Wave Life Sciences (WVE) and Regeneron (REGN)
TipRanks · 6d ago
Analysts Are Bullish on Top Healthcare Stocks: Johnson & Johnson (JNJ), Wave Life Sciences (WVE)
TipRanks · 6d ago
Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE), Liquidia Technologies (LQDA) and Abbott Laboratories (ABT)
TipRanks · 6d ago
Wave Life Sciences Price Target Announced at $10.00/Share by Ladenburg Thalmann
Dow Jones · 10/01 16:26
Midday Fly By: Micron earnings beat, MSG Sports approves Rangers spinoff
TipRanks · 10/01 16:01
More
About WVE
Wave Life Sciences Ltd. is a biotechnology company focused on unlocking the broad potential of ribonucleic acid (RNA) medicines to transform human health. The Company's RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and common disorders. Its toolkit of RNA-targeting modalities includes editing, splicing, RNA interference and antisense silencing, providing Wave with unmatched capabilities for designing and sustainably delivering candidates that optimally address disease biology. The Company's diversified pipeline includes clinical programs in alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease, as well as several preclinical programs utilizing the Company's broad RNA therapeutics toolkit. Its programs include WVE-006, SERPINA1 (AATD); WVE-007 (GalNAc), INHBE (Obesity); WVE-N531, Exon 53 (DMD), and WVE-003, mHTT (HD).

Webull offers Wave Life Sciences Ltd stock information, including NASDAQ: WVE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, WVE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading WVE stock methods without spending real money on the virtual paper trading platform.